Benzodiazepine Taper in a Patient with Anxiety and Substance Use History
A 38-year-old woman with generalized anxiety disorder and a history of alcohol use disorder (in remission for 2 years) has been taking alprazolam 1 mg three times daily for 5 years, prescribed by her primary care physician. She wants to stop because she is planning pregnancy. She reports feeling anxious between doses and sometimes takes an extra dose. She has tried to taper on her own but experienced severe anxiety and insomnia. She denies current alcohol use but admits to occasional cannabis use. Her urine drug screen is negative for benzodiazepines (she ran out 2 days ago) and positive for THC. She is requesting a refill.
1. What are the risks of continuing alprazolam and what is your approach to tapering?
Read the worked answer
Risks include tolerance, dependence, withdrawal seizures, cognitive impairment, falls, and interactions with alcohol or opioids. In pregnancy, benzodiazepines may increase risk of neonatal sedation and withdrawal. Given her history of AUD and current cannabis use, she is at higher risk for misuse. The appropriate approach is a gradual taper. First, stabilize her by restarting alprazolam at the previous dose (1 mg TID) to prevent withdrawal, then convert to an equivalent dose of a long-acting benzodiazepine (e.g., clonazepam or diazepam) to allow smoother tapering. For example, alprazolam 3 mg/day is roughly equivalent to diazepam 30-40 mg/day or clonazepam 1.5 mg/day. Taper by 5-10% every 2-4 weeks, with slower reductions near the end. Provide CBT for anxiety and insomnia. Monitor for withdrawal symptoms. Coordinate with obstetrics if pregnancy occurs.
2. She is reluctant to switch to a longer-acting benzodiazepine. How do you address this?
Read the worked answer
Explain that switching to a longer-acting agent is a strategy to make tapering more comfortable and reduce interdose withdrawal, which is common with alprazolam due to its short half-life. Validate her concerns and emphasize that the goal is to minimize discomfort and prevent relapse. Offer to start with a partial switch or cross-taper slowly. Involve her in the decision. If she refuses, consider a slow taper directly from alprazolam using smaller, more frequent doses (e.g., 0.25 mg reductions every 2 weeks) but warn that withdrawal may be more challenging. Address her anxiety with non-pharmacologic methods and consider adding an SSRI if not contraindicated. Document the discussion.
3. What role does her cannabis use play in this plan?
Read the worked answer
Cannabis use may exacerbate anxiety and interfere with sleep, and it carries risks in pregnancy. It may also indicate a pattern of substance misuse. Discuss the potential negative effects and recommend cessation, especially if she is planning pregnancy. Use motivational interviewing to explore her use. Screen for cannabis use disorder. If she continues, monitor for interactions and encourage reduction. Do not make cannabis cessation a prerequisite for benzodiazepine taper, but incorporate it into the overall plan. Provide education about risks in pregnancy.